TY - JOUR
T1 - The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets
AU - Kobayashi, Kunihisa
AU - Inoguchi, Toyoshi
AU - Maeda, Yasutaka
AU - Nakashima, Naoki
AU - Kuwano, Asako
AU - Eto, Erina
AU - Ueno, Noriko
AU - Sasaki, Shuji
AU - Sawada, Fumi
AU - Fujii, Masakazu
AU - Matoba, Yuka
AU - Sumiyoshi, Shinji
AU - Kawate, Hisaya
AU - Takayanagi, Ryoichi
PY - 2008/7
Y1 - 2008/7
N2 - Context: The molecular mechanisms by which triglycerides in lipid droplets (LDs) are synthesized, stored, and degraded need to be elucidated. Objective: The objectives were to report siblings with neutral lipid storage disease with myopathy (NLSDM) with a novel mutation of adipose triglyceride lipase (ATGL) and determine whether the C-terminal part of ATGL containing the hydrophobic region plays a role in the interaction with LDs. Design and Patients: Skin fibroblasts and peripheral blood leukocytes were obtained from NLSDM patients. In vitro experiments were performed with fibroblasts and COS7 cells. Main Outcome Measures: Transfection studies were used to assess the effects of various recombinant ATGL proteins on lipase activities and lipid contents. Fluorescence microscopy were used for determination of intracellular distribution of ATGL proteins. Results: The direct sequence of ATGL cDNA reveals that a patient is a homozygote for the 4-bp deletion, leading to a premature stop codon and causes the lack of the C terminus of the protein including the hydrophobic domain. Overexpressed control ATGL in NLSDM fibroblasts was found around the rims of LDs and caused significantly reduced cellular lipid accumulation. In contrast, NLSDM ATGL was homogeneously located in the cytoplasm despite the presence of LDs and had almost no effect on LD degradation despite its similar lipase activity. A series of C-terminal truncated ATGLs without the intact hydrophobic domain failed to localize around and degrade LDs. Conclusions: These findings indicate that the domain including the hydrophobic region of ATGL was essential for association with LDs.
AB - Context: The molecular mechanisms by which triglycerides in lipid droplets (LDs) are synthesized, stored, and degraded need to be elucidated. Objective: The objectives were to report siblings with neutral lipid storage disease with myopathy (NLSDM) with a novel mutation of adipose triglyceride lipase (ATGL) and determine whether the C-terminal part of ATGL containing the hydrophobic region plays a role in the interaction with LDs. Design and Patients: Skin fibroblasts and peripheral blood leukocytes were obtained from NLSDM patients. In vitro experiments were performed with fibroblasts and COS7 cells. Main Outcome Measures: Transfection studies were used to assess the effects of various recombinant ATGL proteins on lipase activities and lipid contents. Fluorescence microscopy were used for determination of intracellular distribution of ATGL proteins. Results: The direct sequence of ATGL cDNA reveals that a patient is a homozygote for the 4-bp deletion, leading to a premature stop codon and causes the lack of the C terminus of the protein including the hydrophobic domain. Overexpressed control ATGL in NLSDM fibroblasts was found around the rims of LDs and caused significantly reduced cellular lipid accumulation. In contrast, NLSDM ATGL was homogeneously located in the cytoplasm despite the presence of LDs and had almost no effect on LD degradation despite its similar lipase activity. A series of C-terminal truncated ATGLs without the intact hydrophobic domain failed to localize around and degrade LDs. Conclusions: These findings indicate that the domain including the hydrophobic region of ATGL was essential for association with LDs.
UR - http://www.scopus.com/inward/record.url?scp=47549087164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=47549087164&partnerID=8YFLogxK
U2 - 10.1210/jc.2007-2247
DO - 10.1210/jc.2007-2247
M3 - Article
C2 - 18445677
AN - SCOPUS:47549087164
SN - 0021-972X
VL - 93
SP - 2877
EP - 2884
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 7
ER -